Related Experiment Video
Updated: Dec 6, 2025

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma
Catherine D Yao1, Daniel Haensel1, Sadhana Gaddam1
1Program in Epithelial Biology, Stanford University School of Medicine, 269 Campus Drive, Stanford, CA, 94305, USA.
Abstract:
Tumor heterogeneity and lack of knowledge about resistant cell states remain a barrier to targeted cancer therapies. Basal cell carcinomas (BCCs) depend on Hedgehog (Hh)/Gli signaling, but can develop mechanisms of Smoothened (SMO) inhibitor resistance. We previously identified a nuclear myocardin-related transcription factor (nMRTF) resistance pathway that amplifies noncanonical Gli1 activity, but characteristics and drivers of the nMRTF cell state remain unknown. Here, we use single cell RNA-sequencing of patient tumors to identify three prognostic surface markers (LYPD3, TACSTD2, and LY6D) which correlate with nMRTF and resistance to SMO inhibitors. The nMRTF cell state resembles transit-amplifying cells of the hair follicle matrix, with AP-1 and TGFß cooperativity driving nMRTF activation. JNK/AP-1 signaling commissions chromatin accessibility and Smad3 DNA binding leading to a transcriptional program of RhoGEFs that facilitate nMRTF activity. Importantly, small molecule AP-1 inhibitors selectively target LYPD3+/TACSTD2+/LY6D+ nMRTF human BCCs ex vivo, opening an avenue for improving combinatorial therapies.
Insights
Researchers identified new markers (LYPD3, TACSTD2, LY6D) for resistant basal cell carcinoma (BCC) cell states. Targeting the AP-1 pathway with inhibitors shows promise for treating these resistant BCC tumors.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Tumor heterogeneity and resistance mechanisms hinder effective cancer therapies.
- Basal cell carcinomas (BCCs) often develop resistance to Smoothened (SMO) inhibitors via pathways like nuclear myocardin-related transcription factor (nMRTF).
- The specific characteristics and drivers of the nMRTF resistant cell state in BCCs are not well understood.
Purpose of the Study:
- To identify prognostic surface markers associated with the nMRTF resistant cell state in BCCs.
- To elucidate the molecular drivers and cellular characteristics of nMRTF-mediated SMO inhibitor resistance.
- To evaluate the therapeutic potential of targeting the identified resistance pathways in BCC.
Main Methods:
- Single-cell RNA sequencing (scRNA-seq) of patient-derived BCC tumors.
- Correlation analysis of surface marker expression with nMRTF pathway activation and SMO inhibitor resistance.
- Investigation of signaling pathways (AP-1, TGFß, JNK) involved in nMRTF activation.
- Ex vivo drug sensitivity assays using small molecule AP-1 inhibitors.
Main Results:
- Three prognostic surface markers, LYPD3, TACSTD2, and LY6D, were identified and correlated with the nMRTF cell state and SMO inhibitor resistance.
- The nMRTF cell state shares similarities with hair follicle matrix transit-amplifying cells.
- AP-1 and TGFß signaling cooperativity drives nMRTF activation, involving JNK/AP-1 mediated chromatin accessibility and Smad3 binding.
- Small molecule AP-1 inhibitors demonstrated selective targeting of LYPD3+/TACSTD2+/LY6D+ nMRTF human BCCs ex vivo.
Conclusions:
- LYPD3, TACSTD2, and LY6D are key prognostic markers for a specific resistant BCC cell state.
- The nMRTF cell state is driven by a cooperative signaling network involving AP-1 and TGFß.
- Targeting the AP-1 pathway with small molecule inhibitors offers a promising therapeutic strategy for overcoming SMO inhibitor resistance in BCC.
More Related Videos
Related Concept Videos
Hedgehog Signaling Pathway
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Intracellular Signaling Affects Focal Adhesions
Some...

